Online Drug Supplier 111 Finds Tonic in B2B Focus
Company adds two fulfillment centers, inks deal with cancer drug maker BeiGene, in drive to consolidate its place as premier B2B specialist Key takeaways 111 Inc.’s aggressive pursuit of partnerships…
Recent Articles
RECENT ARTICLES
-
Bumper dividend could trigger buyout for Ping An Health
1833.HK -
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
- Cancer drug maker Genfleet joins Hong Kong IPO influx
- TCMTech fuses old with the new by mixing AI and Chinese medicine
- Saint Bella births Hong Kong IPO, in race to nurture a postpartum empire
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
